Cite
APA Citation
Chuang, W., Jia, J., Chan, H. L. Y., Han, K., Tanwandee, T., Tan, D., Chen, X., Gane, E., Piratvisuth, T., Chen, L., Xie, Q., Sung, J. J., Messinger, D., Wat, C., Bakalos, G., & Liaw, Y. F. (2018). responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patients. Alimentary pharmacology & therapeutics, 47(9), 1306–1316. http://access.bl.uk/ark:/81055/vdc_100060625834.0x00004a